Skip to main content
Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · IEX Real-Time Price · USD
0.879
-0.022 (-2.48%)
At close: May 1, 2024, 4:00 PM
0.910
+0.031 (3.53%)
Pre-market: May 2, 2024, 8:44 AM EDT

Lucid Diagnostics Revenue

In the year 2023, Lucid Diagnostics had annual revenue of $2.43M with 544.03% growth. Revenue in the quarter ending December 31, 2023 was $1.04M with 828.57% year-over-year growth.

Revenue (ttm)
$2.43M
Revenue Growth
+544.03%
P/S Ratio
17.46
Revenue / Employee
$34,686
Employees
70
Market Cap
42.39M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.43M2.05M544.03%
Dec 31, 2022377.00K-123.00K-24.60%
Dec 31, 2021500.00K--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Oncology Network 1.28B
Rapid Micro Biosystems 22.52M
Cara Therapeutics 20.97M
DarioHealth 20.35M
Bolt Biotherapeutics 7.88M
Cyclo Therapeutics 1.08M
Revenue Rankings

LUCD News

More News